[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.187.2. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
October 1956

Retrolental FibroplasiaCooperative Study of Retrolental Fibroplasia and the Use of Oxygen

Author Affiliations

Detroit; Detroit; Ann Arbor
From the Kresge Eye Institute (Dr. Kinsey and Mrs. Jacobus) and the Department of Public Health Statistics, School of Public Health, University of Michigan (Dr. Hemphill).

AMA Arch Ophthalmol. 1956;56(4):481-543. doi:10.1001/archopht.1956.00930040489001
Abstract

(Footnotes continued on next page)

Introduction  Administration of oxygen to premature infants had been implicated as an etiologic agent in the development of retrolental fibroplasia (RLF) prior to late 1952.* But because of the apparently capricious fluctuation in incidence of the disease observed in various communities and the insufficiency of controlled investigations concerning the possible role of oxygen in RLF the evidence was deemed inadequate to justify curtailment of oxygen for premature infants, particularly in the absence of knowledge of the effect on mortality of such a change in procedure.For these reasons a number of pediatricians and ophthalmologists agreed early in 1953 to pool their nursery facilities and interests and investigate cooperatively the question of whether oxygen was in fact an etiologic agent in RLF and at the same time to determine what effect restricting oxygen might have on infant mortality. This group of investigators, from 18 hospitals located

First Page Preview View Large
First page PDF preview
First page PDF preview
×